Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026)
Twist Bioscience (TWST) reported Income from Continuing Operations of 44021000.0 for Q1 2026, down 11.86% year-over-year from 49945463.83 in Q1 2025, and down 44.3% quarter-over-quarter from 30507000.0 in Q4 2025.
Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Twist Bioscience (TWST) has 10 years of Income from Continuing Operations data on file, last reported at 44021000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 44021000.0, down 11.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 81266000.0 (up 57.49% YoY), and the FY2025 annual result was 77651000.0, up 62.8% from the prior year.
- Income from Continuing Operations fell to 44021000.0 in Q1 2026 per TWST's latest filing, from 30507000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 20381000.0 in Q2 2025 and troughed at 85580000.0 in Q2 2024.
- A 5-year average of 43405882.35 and a median of 44021000.0 in 2026 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations plunged 59.99% in 2022, then surged 123.82% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 41824000.0 in 2022, then slipped by 2.83% to 43008000.0 in 2023, then gained by 26.53% to 31597000.0 in 2024, then advanced by 3.45% to 30507000.0 in 2025, then sank by 44.3% to 44021000.0 in 2026.
- Business Quant data shows TWST's Income from Continuing Operations at 44021000.0 in Q1 2026, 30507000.0 in Q4 2025, and 27119000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn | -44.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.02 Mn |
| Dec 31, 2025 | -30.51 Mn |
| Sep 30, 2025 | -27.12 Mn |
| Jun 30, 2025 | 20.38 Mn |
| Mar 31, 2025 | -39.35 Mn |
| Dec 31, 2024 | -31.60 Mn |
| Sep 30, 2024 | -34.65 Mn |
| Jun 30, 2024 | -85.58 Mn |
| Mar 31, 2024 | -45.49 Mn |
| Dec 31, 2023 | -43.01 Mn |
| Sep 30, 2023 | -46.24 Mn |
| Jun 30, 2023 | -57.40 Mn |
| Mar 31, 2023 | -59.18 Mn |
| Dec 31, 2022 | -41.82 Mn |
| Sep 30, 2022 | -51.13 Mn |
| Jun 30, 2022 | -60.52 Mn |
| Mar 31, 2022 | -60.67 Mn |
| Dec 31, 2021 | -45.56 Mn |
| Sep 30, 2021 | -41.27 Mn |
| Jun 30, 2021 | -40.04 Mn |